Navigation Links
Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
Date:6/16/2009

NEW YORK, NY JUNE 16, 2009 The Cardiovascular Research Foundation (CRF) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) were published online June 15 in the journal Circulation. The study also compared the rates of myocardial infarction (MI) and target vessel revascularization (TVR).

The analysiswhich includes approximately 190,000 patients from 56 studieswas performed by a team of researchers led by Ajay J. Kirtane, MD, Assistant Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons; and an interventional cardiologist at NewYork-Presbyterian Hospital/Columbia University Medical Center; and Gregg W. Stone, MD, Immediate Past Chairman of the Cardiovascular Research Foundation; Professor of Medicine at Columbia University College of Physicians and Surgeons; and Director of Cardiovascular Research and Education in the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center.

Drs. Kirtane and Stone conducted two parallel meta-analyses examining DES vs. BMS use in both randomized, controlled trials and in observational registry analyses. The overall analysis represents the largest systematic overview of "real-world" (comprising both on-label and off-label) DES use to date and incorporates an overview of both the published literature as well as several unpublished studies presented at major cardiovascular meetings.

"The findings from these parallel studies are striking," said Dr. Stone.

The meta-analysis of 22 randomized trials included more than 9,000 patients with recent follow-up from previously published trials. According to the results, "DES resulted in no overall differences in death and MI, with a greater than 50% decrease in subsequent target vessel revascularization procedures," said Dr. Stone, adding that these findings are co
'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Broadlane Selects Silver Creek Systems To Accelerate Core Business Analysis And New Client Services
2. Lethality of H1N1 Influenza Virus Increasing According to Latest Replikin Analysis of Virus Peptide Genomic Data
3. Analysis Sheds Light on Proteins Role in Cancer
4. Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis
5. Evidence-Based Analysis of Aspartame Research
6. Ingenuity and Integromics Offer Integration for Comprehensive Genomics Analysis
7. Milliman Analysis: Preparing for Mental Health Parity
8. NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of Chinas Pharma Supply Chain on U.S. Pharmaceuticals
9. Medicaid Health Plans Provide Cost Savings to States and High Quality and Value to Beneficiaries, New Analysis Shows
10. Transplant patients have worse cancer outcomes, analysis shows
11. Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ether procedure done immediately or 3 weeks later,...ay News) -- Timing of surgical repair or reconstru...ffect patient outcome, a new study has found. ,...atic knee dislocations that can occur in high-impa...ime to perform surgery to repair these injuries ha...
(Date:12/4/2009)...N, Dec. 4 Substantial progress has...e community,s ability to diagnose and treat epilep...ilepsy management has not reached most of the 50 m...the nearly three million people in the United Stat...n C. Schachter, M.D., president of the American Ep...
(Date:12/4/2009)... virus will come back during winter isn,t known, C...News) -- The number of states reporting widespread... -- to 25 from a high of 48 just two weeks ago, a ...the supply of H1N1 swine flu vaccine continues to ....S. Centers for Disease Control and Prevention, sa...
(Date:12/4/2009)...edge of risks, many hesitate to take breast cancer...ealthDay News) -- Worries about side effects are a... at high risk for breast cancer are willing to tak... study finds. , In an effort to inform women ab...rs at the University of Michigan Comprehensive Can...
(Date:12/4/2009)...DISON, Wis., Dec. 4 When... Wisconsin Department of Health Services needed to...than ever before. Join Sonic Foundry, Inc. (Nasd... media webcasting and knowledge management, for a ...n Department of Health Services, will share how in...
Breaking Medicine News(10 mins):Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Swine Flu Continues to Wane 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
... Scientists with the Lineberger Comprehensive Canc...hapel Hill have for the first time implicated a g... the inevitable recurrence of advanced prostate ca...es prostate cancer recur in men treated to get rid...
... Researchers at the University of Wisconsin-Madiso... of measuring molecular structures quickly and ac...ld and see the shapes of intermediate steps. ...n that is implicated in type II diabetes. ...
... When compared with intensive drug therapy, percut...s more beneficial in reducing the long-term risk ...rs with 'silent ischemia', according to a study. ...oms of angina (chest pain due to inadequate supply...
... A new study has found that no other lifestyle fac.... A study in the May issue of the Journal ...t have the most impact on periodontal health. ...ferent lifestyle factors on the progression of per...
... A research on animals, conducted by the National ...ence that a chemical referred to as hexavalent chr...med in drinking water. Hexavalent chromiu...The two-year study showed that the mice had develo...
... A review has suggested that women who take a low-...ting, have a reduced risk of pregnancy complicati...31 studies involving more than 32,000 women, found... that women need to be cautious, especially as asp...
Other Medicine News:Health News:Study Implicates Protein as a Trigger of Advanced Prostate Cancer Recurrence 2Health News:New Analytical Tool to Unravel the Cause of Diabetes 2Health News:Angioplasty Reduces Long-term Cardiac Risk in Heart Patients With 'silent' Ischemia 2Health News:Impact of Periodontal Health High With Smoking and Sleeping 2
(Date:12/4/2009)..., Dec. 4 Dynatronics Cor...a sole-source vendor agreement to provide therapy ... Therapy with 65 clinics located in Tennessee and ...le-source supplier to Benchmark Physical Therapy,"...of sales and marketing at Dynatronics. "Benchmark ...
(Date:12/4/2009)...ASHINGTON, Dec. 4 Chem...ublished by the Pharmaceutical Research and Manuf...new drugs and vaccines in development for HIV/AIDS...nd that the 97 products in development include 23 ... in human clinical trials or awaiting approval by ...
(Date:12/4/2009)... Dec. 4 PharmAthene, Inc...ing medical countermeasures against biological and...y is presenting results of a study demonstrating t...n anthrax model in the New Zealand White (NZW) rab...session at the HHS Public Health Emergency Medical...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6NBTY to Web Cast Fiscal Fourth Quarter Conference Call 60597 1NBTY to Web Cast Fiscal Fourth Quarter Conference Call 60597 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 1Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 3Free 2D 3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging 5946 1Free 2D 3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging 5946 2
...detail how some fair coloring traits contribute to... into the deCODEme(TM) service, REYKJAVIK, Icelan...cientists and academic colleagues from Europe and ... in the genetics of pigmentation,traits in people ...of these,common variants also confer risk of two t...
...lmo BioTech Inc. (OTC,Bulletin Board: PLMO.OB) has...of its Phase I Human Trials with its PulmoBind Mol...monary Embolism and Pulmonary,Hypertension., The ...idiary,PulmoScience Inc., and the title of the wor...olecular Imaging of the Pulmonary Circulation.", ...
Other Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: